Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021

• Egile Nagusiak: Rachel E. Bosserman (Egilea), Christopher W. Farnsworth (Egilea), Caroline A. O'Neil (Egilea), Candice Cass (Egilea), Daniel Park (Egilea), Claire Ballman (Egilea), Meghan A. Wallace (Egilea), Emily Struttmann (Egilea), Henry Stewart (Egilea), Olivia Arter (Egilea), Kate Peacock (Egilea), Victoria J. Fraser (Egilea), Philip J. Budge (Egilea), Margaret A. Olsen (Egilea), Carey-Ann D. Burnham (Egilea), Hilary M. Babcock (Egilea), Jennie H. Kwon (Egilea), for the CDC Prevention Epicenters (Egilea)
• Formatua: Liburua
• Argitaratua: Cambridge University Press, 2023-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Objective: To determine the prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG nucleocapsid (N) antibodies among healthcare personnel (HCP) with no prior history of COVID-19 and to identify factors associated with seropositivity. Design: Prospective cohort study. Se...